Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Aug 11;11(8):2069.
doi: 10.3390/microorganisms11082069.

Endemic High-Risk Clone ST277 Is Related to the Spread of SPM-1-Producing Pseudomonas aeruginosa during the COVID-19 Pandemic Period in Northern Brazil

Affiliations

Endemic High-Risk Clone ST277 Is Related to the Spread of SPM-1-Producing Pseudomonas aeruginosa during the COVID-19 Pandemic Period in Northern Brazil

Pabllo Antonny Silva Dos Santos et al. Microorganisms. .

Abstract

Pseudomonas aeruginosa is a high-priority bacterial agent that causes healthcare-acquired infections (HAIs), which often leads to serious infections and poor prognosis in vulnerable patients. Its increasing resistance to antimicrobials, associated with SPM production, is a case of public health concern. Therefore, this study aims to determine the antimicrobial resistance, virulence, and genotyping features of P. aeruginosa strains producing SPM-1 in the Northern region of Brazil. To determine the presence of virulence and resistance genes, the PCR technique was used. For the susceptibility profile of antimicrobials, the Kirby-Bauer disk diffusion method was performed on Mueller-Hinton agar. The MLST technique was used to define the ST of the isolates. The exoS+/exoU- virulotype was standard for all strains, with the aprA, lasA, toxA, exoS, exoT, and exoY genes as the most prevalent. All the isolates showed an MDR or XDR profile against the six classes of antimicrobials tested. HRC ST277 played a major role in spreading the SPM-1-producing P. aeruginosa strains.

Keywords: Pseudomonas aeruginosa; SPM-1; northern region; resistance; virulence.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Similarity and genomic characteristics of XDR SPM-1-producing P. aeruginosa isolated during pandemic period in northern Brazil. (+: positive, −: negative).

Similar articles

Cited by

References

    1. Horcajada J.P., Montero M., Oliver A., Sorlí L., Luque S., Gómez-Zorrilla S., Benito N., Grau S. Epidemiology and Treatment of Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa Infections. Clin. Microbiol. Rev. 2019;32:e00031-19. doi: 10.1128/CMR.00031-19. - DOI - PMC - PubMed
    1. Reynolds D., Kollef M. The Epidemiology and Pathogenesis and Treatment of Pseudomonas aeruginosa Infections: An Update. Drugs. 2021;81:2117–2131. doi: 10.1007/s40265-021-01635-6. - DOI - PMC - PubMed
    1. Sarges E.D.S.N.F., Rodrigues Y.C., Furlaneto I.P., Melo M.V.H.D., Brabo G.L.D.C., Lopes K.C.M., Quaresma A.J.P.G., Lima L., Lima K.V.B. Pseudomonas aeruginosa Type III Secretion System Virulotypes and Their Association with Clinical Features of Cystic Fibrosis Patients. Infect. Drug Resist. 2020;13:3771–3781. doi: 10.2147/IDR.S273759. - DOI - PMC - PubMed
    1. Parkins M.D., Somayaji R., Waters V.J. Epidemiology, Biology, and Impact of Clonal Pseudomonas aeruginosa Infections in Cystic Fibrosis. Clin. Microbiol. Rev. 2018;31:e00019-18. doi: 10.1128/CMR.00019-18. - DOI - PMC - PubMed
    1. Cepas V., Soto S.M. Relationship between Virulence and Resistance among Gram-Negative Bacteria. Antibiotics. 2020;9:719. doi: 10.3390/antibiotics9100719. - DOI - PMC - PubMed

LinkOut - more resources